KYOTO, Japan — The antimalarial drug mefloquine may prove to be an effective treatment for progressive multifocal leukoencephalopathy (PML) in patients not infected with HIV, a small, preliminary ...
Presence and function of CD14+CD16-HLADRlow monocytes in the peripheral blood of patients with Î’-cell non-Hodgkin lymphoma (NHL). Mean age in years at death (sd) 65.1 years (6.9) 67.3 years (6.6) Mean ...
Modulation of lipid rafts (LR), p-glycoprotein (P-gp) and proinflammatory cytokines (PIC) with HMG-Co A reductase inhibitor simvastatin (SV) in chronic myelogenous leukemia (CML) patients with ...
Please provide your email address to receive an email when new articles are posted on . Use of a genetic risk test for patients considering immunosuppressive therapies associated with development of ...
Progressive multifocal leukoencephalopathy (PML) is a rare, fatal disease that causes continual damage to the white matter of the brain, at different locations. Caused by JC Virus, PML is mostly ...
A 34 year-old HIV positive man had declined anti-viral treatment. Over the course of 3 weeks, he developed progressive ataxia affecting the left side. Progressive Multifocal Leukoencephalopathy (PML): ...
The researchers report that adoptive transfer of donor-derived anti-polyomavirus-specific T-cells (PyVSTs) was safe in a small number of patients with refractory PML. "We think this strategy has real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results